Drug Database
Back to search

Norway· NO-ID_F53737FC-5AD1-4433-8D51-7B619638A1B2

Levocarb-GRY

A levodopa und decarboxylasehemmer product containing levodopa + carbidopa monohydrate, registered in Norway by Teva. The same ATC class is registered in 12 of our 19 countries.

ATC N04BA02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedLevocarb-GRYATCN04BA02REGISTER NO.NO-ID_F53737FC-5AD1-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levodopa + carbidopa monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levodopa und decarboxylasehemmer is registered in 12 of 19 countries.

Countries holding a registration under ATC N04BA02 (levodopa und decarboxylasehemmer), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose
Search levodopa und decarboxylasehemmer products by name

Levodopa und decarboxylasehemmer · ATC N04BA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Levodopa + Carbidopa Monohydrate
Manufacturer
Teva
Country
Norway (NO)
ATC code
N04BA02
ATC class
Levodopa und Decarboxylasehemmer
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_F53737FC-5AD1-4433-8D51-7B619638A1B2
  • no_varenummer
    347356
    100
  • gtin
    4150087898727

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for levodopa und decarboxylasehemmer.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levodopa und decarboxylasehemmer against other medicinesHow interaction checks work

Levodopa und decarboxylasehemmer · interactions on record

158 records

  • 4 severe
  • 122 moderate
  • 14 minor

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • Methylthioninium chlorideV03AB17severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levodopa und decarboxylasehemmer in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levodopa und decarboxylasehemmer products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Duodopa
  • Belgium · Duodopa, Precifit
  • Bulgaria · Дуодопа, Синепар
  • Cyprus · Duodopa
  • Czechia · Duodopa, Isicom
  • Germany · Duodopa, Isicom
  • Denmark · Carbidopa/Levodopa Fair-Med, Levodopa/Carbidopa Teva
  • Estonia · Duodopa
  • Spain · Carbidopa/Levodopa Aurovitas, Carbidopa/Levodopa Kern Pharma
  • Finland · Duodopa
  • France · Levodopa Carbidopa Teva
  • United Kingdom (Northern Ireland) · Carbidopa/Levodopa Milpharm, Co-Careldopa
  • Greece · Duodopa
  • Croatia · Duodopa
  • Hungary · Duodopa
  • Ireland · Carbidopa/Levodopa Fair-Med, Duodopa
  • Iceland · Duodopa
  • Italy · Carbidopa E Levodopa Aurobindo, Duodopa
  • Liechtenstein · Duodopa
  • Lithuania · Duodopa, Levodopa/Carbidopa Fairmed
  • Luxembourg · Duodopa, Precifit
  • Latvia · Duodopa
  • Netherlands · Carbidopa / Levodopa Brillpharma, Carbidopa/Levodopa Fair-Med
  • Poland · Precifit
  • Portugal · Duodopa, Levodopa + Carbidopa Generis
  • Romania · Duodopa, Isicom
  • Sweden · Carbidopa/Levodopa Fair-Med, Duodopa
  • Slovenia · Duodopa
  • Slovakia · Duodopa, Isicom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d740aab3-1201-421c-a0d3-5565e7f5d085
GET /v1/drugs/d740aab3-1201-421c-a0d3-5565e7f5d085?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Levodopa og dekarboksylasehemmer",
  "merkevare_id": "ID_F53737FC-5AD1-4433-8D51-7B619638A1B2",
  "name_form_strength": "Levocarb-GRY tab 250 mg/25 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about levodopa und decarboxylasehemmer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console